Atlas Trials

Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation

Clinical trial NCT01660633 · COMPLETED

Trial details

NCT number
NCT01660633
Sponsor
Acrotech Biopharma Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2012-12-01
Primary completion
2014-02-01
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.